EA201792255A1 - Ингибиторы деацетилаз гистонов и композиции и способы их применения - Google Patents

Ингибиторы деацетилаз гистонов и композиции и способы их применения

Info

Publication number
EA201792255A1
EA201792255A1 EA201792255A EA201792255A EA201792255A1 EA 201792255 A1 EA201792255 A1 EA 201792255A1 EA 201792255 A EA201792255 A EA 201792255A EA 201792255 A EA201792255 A EA 201792255A EA 201792255 A1 EA201792255 A1 EA 201792255A1
Authority
EA
Eurasian Patent Office
Prior art keywords
methods
compositions
histone deacetylase
deacetylase inhibitors
inhibitors
Prior art date
Application number
EA201792255A
Other languages
English (en)
Other versions
EA035592B1 (ru
Inventor
Селиа Домингез
Майкл К. Мейллард
Перла Бречча
Алан Ф. Хоган
Ребекка Е. Джарвис
Кристофер А. Лакхерст
Элизабет А. Севилл-Стоунс
Эндрю Дж. Стотт
Аманда Ван Де Пёл
Майкл Уолл
Грант Вишарт
Original Assignee
Сиэйчдиай Фаундэйшн, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Сиэйчдиай Фаундэйшн, Инк. filed Critical Сиэйчдиай Фаундэйшн, Инк.
Publication of EA201792255A1 publication Critical patent/EA201792255A1/ru
Publication of EA035592B1 publication Critical patent/EA035592B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4245—Oxadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • C07D491/107—Spiro-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Предложены определенные ингибиторы деацетилаз гистонов (HDAC) формулы I, содержащие их композиции и способы их применения.
EA201792255A 2015-05-07 2016-05-06 Ингибиторы деацетилаз гистонов и композиции и способы их применения EA035592B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562158379P 2015-05-07 2015-05-07
PCT/US2016/031329 WO2016179550A1 (en) 2015-05-07 2016-05-06 Histone deacetylase inhibitors and compositions and methods of use thereof

Publications (2)

Publication Number Publication Date
EA201792255A1 true EA201792255A1 (ru) 2018-06-29
EA035592B1 EA035592B1 (ru) 2020-07-13

Family

ID=57218066

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201792255A EA035592B1 (ru) 2015-05-07 2016-05-06 Ингибиторы деацетилаз гистонов и композиции и способы их применения

Country Status (13)

Country Link
US (2) US10047073B2 (ru)
EP (1) EP3291809B1 (ru)
JP (1) JP6782255B2 (ru)
KR (1) KR20180002730A (ru)
CN (1) CN107735087B (ru)
AU (1) AU2016256917B2 (ru)
BR (1) BR112017023710B1 (ru)
CA (1) CA2984621C (ru)
EA (1) EA035592B1 (ru)
HK (1) HK1252489A1 (ru)
IL (1) IL255449B2 (ru)
MX (1) MX2017014299A (ru)
WO (1) WO2016179550A1 (ru)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3291810B1 (en) 2015-05-07 2022-08-10 CHDI Foundation, Inc. Histone deacetylase inhibitors and compositions and methods of use thereof
CA2984621C (en) * 2015-05-07 2023-09-26 Chdi Foundation, Inc. Histone deacetylase inhibitors and compositions and methods of use thereof
WO2017211650A1 (en) * 2016-06-09 2017-12-14 Basf Se Substituted oxadiazoles for combating phytopathogenic fungi
WO2018015447A1 (en) * 2016-07-22 2018-01-25 Syngenta Participations Ag Microbiocidal oxadiazole derivatives
WO2018165520A1 (en) 2017-03-10 2018-09-13 Vps-3, Inc. Metalloenzyme inhibitor compounds
WO2019219464A1 (en) 2018-05-15 2019-11-21 Basf Se Substituted trifluoromethyloxadiazoles for combating phytopathogenic fungi
KR102009034B1 (ko) 2019-01-31 2019-08-08 주식회사 아이스크림에듀 학습 분석을 기초로 정보를 제공하는 방법 및 시스템
KR102052844B1 (ko) 2019-01-31 2019-12-05 주식회사 아이스크림에듀 학습 분석 방법 및 시스템
KR102232343B1 (ko) 2019-12-11 2021-03-26 주식회사 아이스크림에듀 인공지능 기반 맞춤형 학습 방법 및 시스템
KR102191670B1 (ko) 2019-12-20 2020-12-16 주식회사 아이스크림에듀 문제은행 및 지식맵 기반 맞춤형 학습 방법 및 시스템
KR102191672B1 (ko) 2019-12-20 2020-12-16 주식회사 아이스크림에듀 학습 분석 및 인공지능 기반 맞춤형 학습 방법 및 시스템
KR102197752B1 (ko) 2019-12-20 2021-01-04 주식회사 아이스크림에듀 맞춤형 자동 문항 생성을 통한 인공지능 기반 학습 방법 및 시스템
KR102191671B1 (ko) 2019-12-20 2020-12-16 주식회사 아이스크림에듀 소셜 러닝 및 e포트폴리오 기반 맞춤형 학습 방법 및 시스템
KR102258235B1 (ko) 2020-02-27 2021-05-31 주식회사 아이스크림에듀 실감 콘텐츠가 적용된 인공지능 기반의 맞춤형 학습 방법 및 시스템
KR102232344B1 (ko) 2020-02-27 2021-03-26 주식회사 아이스크림에듀 빅데이터 및 인공지능 기반의 맞춤형 학습 방법 및 시스템
KR102258234B1 (ko) 2020-02-27 2021-05-31 주식회사 아이스크림에듀 인공지능 가정교사 인터페이스가 적용된 맞춤형 학습 방법 및 시스템
CN111190006A (zh) * 2020-03-09 2020-05-22 上海市东方医院（同济大学附属东方医院） 组蛋白去乙酰化酶6在制备用于评估维持性腹膜透析患者腹膜功能的标志物中的用途
KR102222533B1 (ko) 2020-06-25 2021-03-05 주식회사 아이스크림미디어 고정형 웹 콘텐츠를 반응형 콘텐츠로 자동 변환하는 시스템 및 그 제어방법
WO2022029041A1 (en) * 2020-08-07 2022-02-10 Italfarmaco S.P.A. 2-(4-((5-(benzo[b]thiophen-3-yl)-1h-tetrazol-1-yl)methyl)phenyl)-5-(difluoromethyl)-1,3,4-oxadiazole derivatives and similar compounds as selective inhibitors of histone deacetylase 6 (hdac6) for use in treating e.g. peripheral neuropathy
KR102248960B1 (ko) 2020-08-19 2021-05-07 주식회사 아이스크림에듀 인공지능 학습 플랫폼을 이용한 비즈니스 방법 및 시스템

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006061638A2 (en) * 2004-12-10 2006-06-15 Istituto Di Ricerche Di Biologia Molecolare P Angeletti Spa Heterocycle derivatives as histone deacetylase (hdac) inhibitors
GB0427138D0 (en) * 2004-12-10 2005-01-12 Angeletti P Ist Richerche Bio Therapeutic compounds
JP2013517281A (ja) * 2010-01-13 2013-05-16 テンペロ、ファーマシューティカルズ、インコーポレイテッド 化合物及び方法
ES2560627T3 (es) 2010-01-13 2016-02-22 Tempero Pharmaceuticals, Inc. Compuestos y procedimientos para la inhibición de HDAC
WO2013006408A1 (en) 2011-07-01 2013-01-10 Tempero Pharmaceuticals, Inc. Compounds and methods
JP6047563B2 (ja) * 2011-07-08 2016-12-21 ノバルティス アーゲー 新規トリフルオロメチル−オキサジアゾール誘導体および疾患の治療におけるその使用
WO2013009810A1 (en) 2011-07-13 2013-01-17 Tempero Pharmaceuticals, Inc. Methods of treatment
WO2013009830A1 (en) * 2011-07-13 2013-01-17 Tempero Pharmaceuticals, Inc. Methods of treatment
PL2750677T4 (pl) * 2011-08-30 2017-12-29 Chdi Foundation, Inc. Inhibitory 3-monooksygenazy kinureninowej, kompozycje farmaceutyczne i sposoby ich stosowania
CA2856334A1 (en) * 2011-11-28 2013-06-06 Christina Hebach Novel trifluoromethyl-oxadiazole derivatives and their use in the treatment of disease
CN104244939A (zh) 2012-04-05 2014-12-24 Chdi基金会股份有限公司 犬尿氨酸-3-单加氧酶抑制剂、其药物组合物及其使用方法
CA2984621C (en) * 2015-05-07 2023-09-26 Chdi Foundation, Inc. Histone deacetylase inhibitors and compositions and methods of use thereof
EP3291810B1 (en) 2015-05-07 2022-08-10 CHDI Foundation, Inc. Histone deacetylase inhibitors and compositions and methods of use thereof
PT3328844T (pt) 2015-07-27 2020-03-04 Chong Kun Dang Pharmaceutical Corp Derivados de 1,3,4-oxadiazol sulfamida como inibidor de histona desacetilase 6 e composição farmacêutica compreendendo os mesmos
MY197262A (en) 2015-07-27 2023-06-08 Chong Kun Dang Pharmaceutical Corp 1,3,4-oxadiazole sulfonamide derivative compounds as histone deacetylase 6 inhibitor, and the pharmaceutical composition comprising the same
JP6491393B2 (ja) 2015-08-04 2019-03-27 チョン クン ダン ファーマシューティカル コーポレーション ヒストン脱アセチル化酵素６阻害剤としての１，３，４−オキサジアゾール誘導体化合物及びこれを含有する薬剤学的組成物

Also Published As

Publication number Publication date
CA2984621A1 (en) 2016-11-10
CN107735087A (zh) 2018-02-23
AU2016256917B2 (en) 2021-08-26
BR112017023710A2 (pt) 2018-07-31
EP3291809A1 (en) 2018-03-14
MX2017014299A (es) 2018-08-09
IL255449B2 (en) 2023-07-01
AU2016256917A1 (en) 2017-11-23
IL255449A0 (en) 2017-12-31
US20160333001A1 (en) 2016-11-17
EP3291809B1 (en) 2021-08-25
CN107735087B (zh) 2021-09-03
EP3291809A4 (en) 2018-10-03
WO2016179550A1 (en) 2016-11-10
JP2018515492A (ja) 2018-06-14
JP6782255B2 (ja) 2020-11-11
US10047073B2 (en) 2018-08-14
HK1252489A1 (zh) 2019-05-24
US20190185463A1 (en) 2019-06-20
CA2984621C (en) 2023-09-26
EA035592B1 (ru) 2020-07-13
BR112017023710B1 (pt) 2023-03-07
KR20180002730A (ko) 2018-01-08
IL255449B1 (en) 2023-03-01

Similar Documents

Publication Publication Date Title
EA201792255A1 (ru) Ингибиторы деацетилаз гистонов и композиции и способы их применения
EA202091186A1 (ru) ИНГИБИТОРЫ KRas G12C
EA201890749A1 (ru) ИНГИБИТОРЫ АЦЕТИЛ-КоА-КАРБОКСИЛАЗЫ (ACC) И ИХ ПРИМЕНЕНИЕ
MA44990A (fr) Polythérapies d'inhibiteurs de hdac et d'inhibiteurs de pd-l1
EA201792247A1 (ru) Ингибиторы деацетилаз гистонов и композиции и способы их применения
EA201792673A1 (ru) 3-арил-4-амидобициклические [4,5,0] гидроксамовые кислоты в качестве ингибиторов hdac
TN2017000092A1 (en) Benzyl substituted indazoles as bub1 inhibitors.
EA201792028A1 (ru) Альфа-цинамидные соединения и композиции как ингибиторы hdac8
MX2020009870A (es) Inhibidores de histona desacetilasa.
EA201691512A1 (ru) Бензохинолиновые ингибиторы везикулярного переносчика моноамина 2
EP3624804A4 (en) HISTONE DEACETYLASIS INHIBITORS (HDACS)
MX2016014911A (es) Acidos hidroxamicos heterociclicos como inhibidores de proteina desacetilasa e inhibidores dobles de proteina desacetilasa-proteina cinasa, y metodos de uso de los mismos.
MA47305A (fr) Inhibiteurs bicycliques d'histone désacétylase
EA201590028A1 (ru) Ингибиторы гистондеацетилазы и их композиции и способы их применения
DK3653620T3 (da) Nye heteroarylamid-derivater som selektive inhibitorer af histondeacetylaser 1 og 2 (HDAC1-2)
EA201890364A1 (ru) СОЕДИНЕНИЯ, ПРИГОДНЫЕ ДЛЯ ИНГИБИРОВАНИЯ ROR-ГАММА-t
MX2017015900A (es) Metodos para hacer inhibidores de la proteina deacetilasa.
EA202190070A1 (ru) Бициклические ингибиторы гистондеацетилазы
EA201792262A1 (ru) Пироглутамат вортиоксетина
NZ711585A (en) Hdac inhibitors
BR112017028139A2 (pt) inibidores de histona desacetilase
MA49839A (fr) Inhibiteurs bicycliques d'histone désacétylase
IL279940A (en) Histone deacetylase inhibitors
EA201792093A1 (ru) 2-тиопиримидиноны
EA202092514A1 (ru) Изоиндолины в качестве ингибиторов hdac

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG TJ TM